What People Actually Use Instead of Hyperbaric Chambers
The last few years have been brutal for anyone who's been recommending HBOT to patients without a clear indication. Insurance coverage evaporated, waitlists went to months, and the cost per session made it inaccessible for most people who weren't dealing with necrotizing fasciitis or radiation osteonecrosis. So people started looking around. I've spent the better part of three years tracking what actually works, what's a waste of money, and what makes things worse. Here's what I've found. The most straightforward alternative is topical normobaric oxygen delivery. These are the small chambers that sit over a wound or affected area and deliver 100% oxygen at atmospheric pressure. They're used extensively in wound care clinics for diabetic foot ulcers and pressure injuries. The mechanism is different from whole-body HBOT — you're not getting increased plasma-dissolved oxygen throughout the entire body — but for localized tissue hypoxia, the difference is negligible. A wound bed that's chronically starved of oxygen will respond to normobaric 100% O2 just fine, and you're not compressing a patient into a tube for two hours. The catch is that the evidence base for topical normobaric oxygen is thin. Most of the studies are small, industry-sponsored, and focus on wound healing outcomes that are easy to measure (closure rate, time to closure) rather than hard endpoints. That doesn't mean it doesn't work. It means you should calibrate your expectations. A chronic venous ulcer that's been open for eight months isn't going to close because you added another modality. But it might prevent further degradation, and that's worth something.
Then there's the supplement route, which is where things get complicated. Oral nitrates — beetroot juice concentrate, sodium nitrite supplements — have real physiologic effects on vasodilation and tissue perfusion. Nitric oxide signaling improves microcirculation, and in conditions where hypoxia is driven by poor perfusion rather than absolute oxygen deficiency, that's meaningful. I had a patient with refractory post-radiation soft tissue injury in the pelvic region who couldn't tolerate HBOT due to claustrophobia. We loaded her with standardized beetroot extract (around 500mg nitrate daily) and paired it with low-intensity exercise. Within six weeks, the wound edges started showing granulation where there was none for months. It wasn't a cure, but it was directionally correct. The problem with the supplement approach is dosing consistency. A single beetroot juice study might show benefit, but commercial products vary wildly in nitrate content. I once reviewed patient records where the same "brand" had different nitrate concentrations between batches — you're not getting a reproducible dose. Sodium nitrite capsules are more standardized, but they're prescription-only in some jurisdictions and carry real risk if dosed incorrectly. Hypotension is the immediate concern; methemoglobinemia is the long-term concern if someone runs high doses for weeks without monitoring. Exercise-based interventions deserve more attention than they get. The principle is simple: acute aerobic exercise increases cardiac output and shifts oxygen delivery patterns in ways that mimic some of the hemodynamic effects of HBOT. You're not raising tissue PO2 to 2,000 mmHg, but you are improving microvascular recruitment and upregulating angiogenic factors. The protocol that has the most data behind it is moderate-intensity continuous training at 60-75% max heart rate for 30-45 minutes, three to five times per week. Interval training shows promise too but is harder to standardize across a population.
I ran into a situation last year where a patient with chronic non-healing skeletal issues was told they needed HBOT for the third consecutive year. Their insurance had dropped coverage, and they were paying out of pocket at nearly $300 per session. We shifted them to a structured walking program combined with topical normobaric oxygen at home. The walking alone improved their pain scores and functional capacity within four weeks. The topical oxygen didn't change the bone pathology, but it kept the overlying soft tissue healthy, which is where the real clinical bottleneck was. That patient is still doing the protocol eighteen months later, and the only thing they lost was the drive to a hyperbaric facility twice a week. Photobiomodulation is another option that gets dismissed too quickly, particularly in its lower-end device forms. Red and near-infrared light at 600-1000nm wavelengths stimulates cytochrome c oxidase in mitochondria, which increases ATP production and modulates reactive oxygen species signaling. The evidence is strongest for tendinopathies and superficial wound healing. For deeper tissue or systemic effects, the penetration depth of commercially available devices is limiting — most drop off significantly after 2-3cm of tissue. I once had a client who bought a cheap PBMT panel off a marketplace and complained it did nothing. The panel was rated at 5mW/cm2 at the surface and delivered maybe 1mW/cm2 at 5cm depth. You'd need multiple sessions over months to see anything at that intensity. Medical-grade devices operate in the 100-500mW/cm2 range. The technology is sound; the price gap tells you what you're paying for. There's also the question of intermittent hypoxic conditioning, which is the inverse approach. Instead of adding oxygen, you expose the body to controlled periods of low oxygen — typically simulated altitude at 2,500-3,000 meters for 30-60 minutes per session. The adaptation response includes upregulation of EPO, VEGF, and other hypoxia-inducible factors. This has legitimate use in athletic performance and is being studied for various ischemic conditions. The safety profile is good for healthy individuals but problematic for anyone with cardiovascular disease, uncontrolled hypertension, or certain pulmonary conditions. I wouldn't recommend this as a first-line alternative without proper screening.
Get the Full Details
What doesn't work and shouldn't be sold as an alternative is home oxygen therapy using a standard concentrator set to 2-4 liters per minute via nasal cannula. The partial pressure of oxygen in arterial blood at room pressure with supplemental O2 never comes close to the levels achieved in HBOT. You're treating the symptom (low SpO2) rather than the mechanism (impaired tissue oxygen utilization under pressure). For a patient with COPD or sleep apnea, this is appropriate. For someone seeking HBOT-level tissue oxygenation, it's placebo at best. My practical recommendation, assuming someone is looking for something actionable: start with topical normobaric oxygen for localized issues, evaluate nitrate supplementation for perfusion problems if they can afford consistent dosing, and commit to a structured exercise protocol regardless of the condition. The combination of those three covers the majority of cases where HBOT was previously the default answer. Everything else is either too niche, too risky, or too poorly standardized to recommend broadly.
